STOCK TITAN

HNI CEO sells 1,504 shares at $50 after exercise

HNI CORP (HNI) President & CEO Jeffrey D. Lorenger reported an options exercise and share sale.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

HNI CORP (HNI) President & CEO Jeffrey D. Lorenger reported an options exercise and share sale. On August 28, 2026, he exercised 1,504 non‑qualifying employee stock options at an exercise price of $38.68 per share, receiving 1,504 shares of common stock, then sold those 1,504 shares at $50.00 per share. The filing notes the transactions were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026. Following the exercise, he held 27,048 options directly and indirect common stock holdings of 313,061.462 shares by trust and 7,674.193 shares through a Profit Sharing Retirement Plan.

Positive

  • None.

Negative

  • None.
Insider Lorenger Jeffrey D
Role President & CEO
Sold 1,504 shs ($75K)
Approx. gross sale proceeds $75K
Approx. exercise cost $58K
Approx. pre-tax spread $17K
Type Security Shares Price Value
Exercise Non-qualifying employee stock option (right to buy) 1,504 $0.00 $0.00
Exercise Common Stock 1,504 $38.68 $58K
Sale Common Stock F1, F2 1,504 $50.00 $75K
holding Common Stock -- -- --
holding Common Stock -- -- --
Holdings After Transaction: Non-qualifying employee stock option (right to buy) — 27,048 contracts (Direct); Common Stock — 148,490 shares (Direct); Common Stock — 313,061.462 shares (Indirect, By Trust); Common Stock — 7,674.193 shares (Indirect, Profit Sharing Retirement Plan)
Footnotes (2)
  1. F1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026.
  2. F2. The dollar amount in column 4 is a result of multiple lots for the same price that have been combined.
Options exercised 1,504 shares Non-qualifying employee stock option exercised on August 28, 2026
Exercise price $38.68 per share Exercise price of non-qualifying employee stock option
Shares sold 1,504 shares HNI common stock sold on August 28, 2026
Sale price $50.00 per share Price for the 1,504 HNI common shares sold
Options held after transaction 27,048 options Directly held non-qualifying employee stock options after exercise
Indirect trust holdings 313,061.462 shares HNI common stock held indirectly by trust
Profit Sharing Retirement Plan holdings 7,674.193 shares HNI common stock held indirectly via Profit Sharing Retirement Plan
Rule 10b5-1 plan adoption date February 27, 2026 Plan under which the reported transactions were effected
Non-qualifying employee stock option financial
"security_title: "Non-qualifying employee stock option (right to buy)""
Rule 10b5-1 plan regulatory
"transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
Profit Sharing Retirement Plan financial
"nature_of_ownership: "Profit Sharing Retirement Plan""

FAQ

What transactions did HNI (HNI) CEO Jeffrey D. Lorenger report on August 28, 2026?

He exercised 1,504 stock options at an exercise price of $38.68 per share into 1,504 shares of HNI common stock, then sold those 1,504 shares at $50.00 per share on August 28, 2026.

Were Jeffrey D. Lorenger’s HNI (HNI) trades made under a Rule 10b5-1 plan?

Yes. A footnote states the transactions reported were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026, indicating they followed a pre‑arranged trading plan.

How many HNI (HNI) options does Jeffrey D. Lorenger hold after this Form 4?

After exercising 1,504 options, Jeffrey D. Lorenger held 27,048 non‑qualifying employee stock options directly, according to the reported post‑transaction holdings for that option grant.

What are Jeffrey D. Lorenger’s indirect HNI (HNI) share holdings?

Indirectly, he holds 313,061.462 HNI common shares "By Trust" and 7,674.193 shares through a Profit Sharing Retirement Plan, as reported in the indirect ownership holding entries.

How many HNI (HNI) shares did Jeffrey D. Lorenger sell in this Form 4 filing?

He sold 1,504 shares of HNI common stock at a reported price of $50.00 per share, following the exercise of an equal number of stock options the same day.

What does the footnote about multiple lots mean in the HNI (HNI) Form 4?

One footnote explains that the dollar amount in the sale’s price column is a result of multiple lots for the same price that have been combined, clarifying how the reported per‑share price was derived.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Lorenger Jeffrey D

(Last)(First)(Middle)
600 EAST SECOND STREET

(Street)
MUSCATINE IOWA 52761

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HNI CORP [ HNI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President & CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/28/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/28/2026M1,504A$38.68149,994D
Common Stock08/28/2026S(1)1,504D$50(2)148,490D
Common Stock313,061.462IBy Trust
Common Stock7,674.193IProfit Sharing Retirement Plan
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-qualifying employee stock option (right to buy)$38.6808/28/2026M1,50402/14/202202/14/2028Common Stock1,504$027,048D
Explanation of Responses:
1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted on February 27, 2026.
2. The dollar amount in column 4 is a result of multiple lots for the same price that have been combined.
Remarks:
/s/ Steven M. Bradford; by Power of Attorney09/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)